IKNA
Price:
$17.16
Market Cap:
$67.67M
Ikena Oncology, Inc. is a biopharmaceutical company specializing in precision oncology. Its primary objective is to create therapeutic agents specifically formulated for patient populations identified through biomarkers, thereby addressing significant unmet medical needs. The company's leading drug candidate is IK-930, an orally administered small molecule designed to inhibit the transcriptional enhanced associate domain (TEAD) transcription factor, a key component of the Hippo signaling pathway. Ikena is also progressing a portfolio of other investigational therapies, including: A small molecule inhibitor program targeting ERK5 within the RAS signaling pathway. IK-175, an oral compound that...[Read more]
Industry
Biotechnology
IPO Date
2021-03-26
Stock Exchange
NASDAQ
Ticker
IKNA
According to Ikena Oncology, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.23. This represents a change of -88.07% compared to the average of -18.73 of the last 4 quarters.
The mean historical PE Ratio of Ikena Oncology, Inc. over the last ten years is -185.63. The current -2.23 PE Ratio has changed 20.37% with respect to the historical average. Over the past ten years (40 quarters), IKNA's PE Ratio was at its highest in in the December 2021 quarter at 482.31. The PE Ratio was at its lowest in in the December 2019 quarter at -480.00.
Average
-185.63
Median
-70.41
Minimum
-817.02
Maximum
-0.64
Discovering the peaks and valleys of Ikena Oncology, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 142.55%
Maximum Annual PE Ratio = -0.64
Minimum Annual Increase = -96.68%
Minimum Annual PE Ratio = -817.02
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.64 | -96.68% |
| 2024 | -19.29 | 33.03% |
| 2023 | -14.50 | -13.67% |
| 2022 | -16.80 | -89.39% |
| 2021 | -158.40 | 30.35% |
| 2020 | -121.52 | -85.13% |
| 2019 | -817.02 | 142.55% |
The current PE Ratio of Ikena Oncology, Inc. (IKNA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-11.48
5-year avg
-41.93
10-year avg
-185.63
Ikena Oncology, Inc.’s PE Ratio is less than ASLAN Pharmaceuticals Limited (-0.06), greater than Exscientia plc (-3.11), greater than Icosavax, Inc. (-6.88), greater than Avid Bioservices, Inc. (-5.61), greater than Chimerix, Inc. (-8.67), greater than Sage Therapeutics, Inc. (-2.62), less than Intercept Pharmaceuticals, Inc. (5.58), greater than Invivyd, Inc. (-2.59), greater than iTeos Therapeutics, Inc. (-2.82), less than Niagen Bioscience Inc (14.94),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.06 | $777.12M | |
| -3.11 | $633.18M | |
| -6.88 | $769.04M | |
| -5.61 | $798.90M | |
| -8.67 | $801.08M | |
| -2.62 | $544.94M | |
| 5.58 | $794.69M | |
| -2.59 | $128.73M | |
| -2.82 | $448.68M | |
| 14.94 | $278.76M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ikena Oncology, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ikena Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Ikena Oncology, Inc.'s PE Ratio?
How is the PE Ratio calculated for Ikena Oncology, Inc. (IKNA)?
What is the highest PE Ratio for Ikena Oncology, Inc. (IKNA)?
What is the 3-year average PE Ratio for Ikena Oncology, Inc. (IKNA)?
What is the 5-year average PE Ratio for Ikena Oncology, Inc. (IKNA)?
How does the current PE Ratio for Ikena Oncology, Inc. (IKNA) compare to its historical average?